The United States also pays more than double the price charged in Europe for these drugs - so-called tyrosine kinase inhibitors (TKIs), a potent class of cancer pills with fewer side effects than chemotherapy. The analysis by pharmacologist Andrew Hill of Britain's University of Liverpool, who will present his findings at the Sept. 25-29 European Cancer Congress in Vienna, is likely to fuel a growing storm over U.S. drug costs.
NEW YORK (AP) — A woman in a head scarf gazes piercingly from the side of a Brooklyn brownstone. A flock of spray-painted birds breaks free from shackles on a Manhattan building. A Harlem mural shows a giant teal gazelle against a black background, barren trees and a peacock feather.